Reuters logo
BRIEF-Bluebird Bio says to receive $15 mln option exercise payment from Celgene​
September 28, 2017 / 8:19 PM / 3 months ago

BRIEF-Bluebird Bio says to receive $15 mln option exercise payment from Celgene​

Sept 28 (Reuters) - Bluebird Bio Inc

* Bluebird Bio Inc - to receive $15 million option exercise payment from Celgene​

* Bluebird Bio Inc - Celgene has exercised its option to exclusively license bb21217 under its collaboration with Bluebird Bio Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below